DDX50 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.451600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.108400E-01
Normal-vs-Stage2
4.369000E-01
Normal-vs-Stage3
1.724410E-01
Normal-vs-Stage4
6.880200E-01
Stage1-vs-Stage2
7.624000E-01
Stage1-vs-Stage3
3.088400E-01
Stage1-vs-Stage4
6.998100E-02
Stage2-vs-Stage3
2.092600E-01
Stage2-vs-Stage4
1.732230E-01
Stage3-vs-Stage4
7.280000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.549200E-01
Normal-vs-AfricanAmerican
9.271400E-01
Normal-vs-Asian
8.688200E-02
Caucasian-vs-AfricanAmerican
3.622600E-01
Caucasian-vs-Asian
1.549830E-01
AfricanAmerican-vs-Asian
5.522400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.731400E-01
Normal-vs-Female
4.230600E-01
Male-vs-Female
9.456000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.857200E-01
Normal-vs-Age(41-60Yrs)
8.619600E-01
Normal-vs-Age(61-80Yrs)
3.189400E-01
Normal-vs-Age(81-100Yrs)
2.891600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.107400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.566600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.892000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.555200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.243000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.642400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.952440E-01
Normal-vs-Daily Drinker
3.499600E-01
Normal-vs-Weekly Drinker
3.169400E-01
Normal-vs-Occasional Drinker
9.788000E-01
Normal-vs-Social Drinker
6.567000E-01
Non Drinker-vs-Daily Drinker
5.575400E-01
Non Drinker-vs-Weekly Drinker
4.356200E-01
Non Drinker-vs-Occasional Drinker
1.137640E-02
Non Drinker-vs-Social Drinker
1.918370E-01
Daily Drinker-vs-Weekly Drinker
8.347800E-01
Daily Drinker-vs-Occasional Drinker
7.082300E-02
Daily Drinker-vs-Social Drinker
4.633400E-01
Weekly Drinker-vs-Occasional Drinker
1.087370E-01
Weekly Drinker-vs-Social Drinker
5.953800E-01
Occasional Drinker-vs-Social Drinker
4.021000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.122400E-01
Normal-vs-Grade 2
5.906200E-01
Normal-vs-Grade 3
6.102400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.333630E-01
Grade 1-vs-Grade 3
2.546600E-01
Grade 1-vs-Grade 4
3.122400E-01
Grade 2-vs-Grade 3
6.227600E-01
Grade 2-vs-Grade 4
5.906200E-01
Grade 3-vs-Grade 4
6.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.693400E-01
Normal-vs-NonDiabetic
3.392000E-01
Diabetic-vs-NonDiabetic
6.608400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.689200E-01
Normal-vs-NoPancreatitis
4.013200E-01
Pancreatitis-vs-NoPancreatitis
7.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.889000E-01
Normal-vs-N1
4.403600E-01
N0-vs-N1
6.729400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.506600E-01
Normal-vs-TP53-NonMutant
5.999800E-01
TP53-Mutant-vs-TP53-NonMutant
7.614400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
